Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184

Similar articles for PubMed (Select 22298767)

1.

Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.

Zhu NL, Asahina K, Wang J, Ueno A, Lazaro R, Miyaoka Y, Miyajima A, Tsukamoto H.

J Biol Chem. 2012 Mar 23;287(13):10355-67. doi: 10.1074/jbc.M111.312751. Epub 2012 Feb 1.

2.

The Necdin-Wnt pathway causes epigenetic peroxisome proliferator-activated receptor gamma repression in hepatic stellate cells.

Zhu NL, Wang J, Tsukamoto H.

J Biol Chem. 2010 Oct 1;285(40):30463-71. doi: 10.1074/jbc.M110.156703. Epub 2010 Jul 27.

3.

Wnt signaling in liver fibrosis: progress, challenges and potential directions.

Miao CG, Yang YY, He X, Huang C, Huang Y, Zhang L, Lv XW, Jin Y, Li J.

Biochimie. 2013 Dec;95(12):2326-35. doi: 10.1016/j.biochi.2013.09.003. Epub 2013 Sep 13. Review.

PMID:
24036368
4.

Pigment epithelium-derived factor 34-mer peptide prevents liver fibrosis and hepatic stellate cell activation through down-regulation of the PDGF receptor.

Tsai TH, Shih SC, Ho TC, Ma HI, Liu MY, Chen SL, Tsao YP.

PLoS One. 2014 Apr 24;9(4):e95443. doi: 10.1371/journal.pone.0095443. eCollection 2014. Erratum in: PLoS One. 2014;9(9): doi/10.1371/journal.pone.0108835.

5.

Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis.

Cheng JH, She H, Han YP, Wang J, Xiong S, Asahina K, Tsukamoto H.

Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G39-49. Epub 2007 Nov 15.

6.

Delta-like 1 serves as a new target and contributor to liver fibrosis down-regulated by mesenchymal stem cell transplantation.

Pan RL, Wang P, Xiang LX, Shao JZ.

J Biol Chem. 2011 Apr 8;286(14):12340-8. doi: 10.1074/jbc.M110.194498. Epub 2011 Jan 14.

7.

Morphogens and hepatic stellate cell fate regulation in chronic liver disease.

Tsukamoto H, Zhu NL, Wang J, Asahina K, Machida K.

J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:94-8. doi: 10.1111/j.1440-1746.2011.07022.x. Review.

8.

Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor γ in hepatic stellate cells for their antifibrotic effect.

Yang MD, Chiang YM, Higashiyama R, Asahina K, Mann DA, Mann J, Wang CC, Tsukamoto H.

Hepatology. 2012 Apr;55(4):1271-81. doi: 10.1002/hep.24792. Epub 2012 Mar 1.

9.

Curcumin regulates delta-like homolog 1 expression in activated hepatic stellate cell.

Qiu J, Zhou Q, Zhai X, Jia X, Zhou Y.

Eur J Pharmacol. 2014 Apr 5;728:9-15. doi: 10.1016/j.ejphar.2014.01.074. Epub 2014 Feb 15.

PMID:
24534491
10.

Schistosoma japonicum egg antigen up-regulates fibrogenesis and inhibits proliferation in primary hepatic stellate cells in a concentration-dependent manner.

Liu P, Wang M, Lu XD, Zhang SJ, Tang WX.

World J Gastroenterol. 2013 Feb 28;19(8):1230-8. doi: 10.3748/wjg.v19.i8.1230.

11.

Depletion of β-arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway.

Sun WY, Song Y, Hu SS, Wang QT, Wu HX, Chen JY, Wei W.

J Cell Biochem. 2013 May;114(5):1153-62. doi: 10.1002/jcb.24458.

PMID:
23192415
12.

Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.

Troeger JS, Mederacke I, Gwak GY, Dapito DH, Mu X, Hsu CC, Pradere JP, Friedman RA, Schwabe RF.

Gastroenterology. 2012 Oct;143(4):1073-83.e22. doi: 10.1053/j.gastro.2012.06.036. Epub 2012 Jun 27.

13.

Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.

Yu J, Zhang S, Chu ES, Go MY, Lau RH, Zhao J, Wu CW, Tong L, Zhao J, Poon TC, Sung JJ.

Int J Biochem Cell Biol. 2010 Jun;42(6):948-57. doi: 10.1016/j.biocel.2010.02.006. Epub 2010 Feb 13.

PMID:
20156580
14.

Downregulation of the Wnt antagonist Dkk2 links the loss of Sept4 and myofibroblastic transformation of hepatic stellate cells.

Yanagida A, Iwaisako K, Hatano E, Taura K, Sato F, Narita M, Nagata H, Asechi H, Uemoto S, Kinoshita M.

Biochim Biophys Acta. 2011 Nov;1812(11):1403-11. doi: 10.1016/j.bbadis.2011.06.015. Epub 2011 Jul 6.

15.

β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation.

Ge WS, Wang YJ, Wu JX, Fan JG, Chen YW, Zhu L.

Mol Med Rep. 2014 Jun;9(6):2145-51. doi: 10.3892/mmr.2014.2099. Epub 2014 Apr 1.

16.

Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis.

Son G, Hines IN, Lindquist J, Schrum LW, Rippe RA.

Hepatology. 2009 Nov;50(5):1512-23. doi: 10.1002/hep.23186.

18.

R-spondin2 activates hepatic stellate cells and promotes liver fibrosis.

Yin X, Yi H, Wu W, Shu J, Wu X, Yu L.

Dig Dis Sci. 2014 Oct;59(10):2452-61. doi: 10.1007/s10620-014-3208-1. Epub 2014 May 23.

PMID:
24852883
19.

Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation.

Jiang F, Parsons CJ, Stefanovic B.

J Hepatol. 2006 Sep;45(3):401-9. Epub 2006 May 3.

PMID:
16780995
20.

MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.

Tu X, Zhang H, Zhang J, Zhao S, Zheng X, Zhang Z, Zhu J, Chen J, Dong L, Zang Y, Zhang J.

J Pathol. 2014 Sep;234(1):46-59. doi: 10.1002/path.4373. Epub 2014 Jun 17.

PMID:
24817606
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk